MedPath

国药集团工业有限公司

Ownership
-
Established
2002-12-30
Employees
-
Market Cap
-
Website
www.cnpicl.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

45

NMPA:45

Drug Approvals

Quetiapine Fumarate Extended-Release Tablets

Product Name
富马酸喹硫平缓释片
Approval Number
国药准字H20253944
Approval Date
Apr 15, 2025
NMPA

Povidone Iodine Suppositories

Product Name
聚维酮碘栓
Approval Number
国药准字H31021030
Approval Date
Nov 5, 2024
NMPA

Tegafur Suppositories

Product Name
替加氟栓
Approval Number
国药准字H31022503
Approval Date
Nov 5, 2024
NMPA

Glycerol Suppositories

Product Name
甘油栓
Approval Number
国药准字H31020394
Approval Date
Nov 5, 2024
NMPA

Paracetamol Suppositories

Product Name
对乙酰氨基酚栓
Approval Number
国药准字H31020393
Approval Date
Nov 5, 2024
NMPA

Terconazole Vaginal Suppositories

Product Name
特康唑阴道栓
Approval Number
国药准字H20090339
Approval Date
Apr 23, 2024
NMPA

Omeprazole Enteric-coated Tablets

Product Name
奥美拉唑肠溶片
Approval Number
国药准字H20094110
Approval Date
Apr 23, 2024
NMPA

Nifedipine Sustained-release Tablets(Ⅱ)

Product Name
硝苯地平缓释片(Ⅱ)
Approval Number
国药准字H20237166
Approval Date
Dec 4, 2023
NMPA

风寒砂熨剂

Approval Number
国药准字Z20027064
Approval Date
Oct 27, 2023
NMPA

Tinidazole Suppositories

Product Name
替硝唑栓
Approval Number
国药准字H20084003
Approval Date
Nov 28, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.